Merck News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

17.05.17	Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO 2017 (PR Newswire)
17.05.17	Merck erhält Indikationserweiterung für Glucophage® SR bei Patienten mit hohem Risiko für Typ-2-Diabetes in Grossbritannien (PR Newswire)
17.05.17	Merck's Glucophage® SR Receives Label Extension for Patients at High Risk of Type 2 Diabetes in the UK (PR Newswire)
15.05.17	Drug Makers Stocks Under Scanner -- Alliqua BioMedical, AbbVie, Johnson & Johnson, and Merck (PR Newswire)
11.05.17	Merck Posting Notable Gain In Afternoon Trading (RTTNews)
11.05.17	FDA Nod For MRK's Keytruda, SGMO Soars On Gene Therapy Deal, OMER Catches Eyes (RTTNews)
10.05.17	European Commission Grants Approval for Merck's New Pergoveris® Pen for Fertility Treatment (PR Newswire)
02.05.17	Four Seasons Hotels and Resorts Appoints Julia Hartz to Board of Directors (PR Newswire)
02.05.17	Merck Q1 Results Beat Estimates; Raises 2017 Outlook (RTTNews)
02.05.17	Merck & Co Inc. Bottom Line Drops 2% In Q1 (RTTNews)
28.04.17	Investigational Cladribine Tablets Data Show Greater Treatment Effect in Relapsing MS Patients at a Higher Risk of Disease Progression (PR Newswire)
25.04.17	America's Diabetes Challenge Unveils Common Challenges Affecting the Type 2 Diabetes Community (PR Newswire)
24.04.17	PDL BioPharma Settles Keytruda Patent Infringement Lawsuit With Merck (RTTNews)
24.04.17	Biotech Stocks Facing FDA Decision In May (RTTNews)
21.04.17	Merck to Present Rebif® (interferon beta-1a) and Investigational Cladribine Tablets Data at AAN 2017 (PR Newswire)
18.04.17	5 Stocks to Watch as Canada Gets Hooked on Cannabis (PR Newswire)
13.04.17	"New York Times" Bestselling Author Tony Tjan Comments on United Airlines Incident (PR Newswire)
10.04.17	Drug Makers Stocks on Investors' Radar -- Pfizer, Merck, Johnson & Johnson, and AbbVie (PR Newswire)
07.04.17	Merck Gets CRL From FDA For TECOS Study With Sitagliptin (RTTNews)
31.03.17	Incyte, Merck Give Further Details On Epacadostat - KEYTRUDA Clinical Program (RTTNews)
24.03.17	Investors: covered-call reports for Bank of America, The Home Depot Inc., Merck & Company Incorporated, Oclaro Inc. and Square Incorporated. (PR Newswire)
24.03.17	Merck Says EMA's CHMP Adopts Positive Opinion Recommending Approval Of KEYTRUDA (RTTNews)
15.03.17	FDA Panel Snubs ENDP, Watch Out For TCON, MRK's Keytruda Scores Another Win (RTTNews)
13.03.17	OilPrice.com: The Next Big Biotech Breakthrough Could Just be on the Horizon (PR Newswire)
10.03.17	New Merck Technology Aims to Further Optimize Embryo Incubation and Assessment (PR Newswire)
07.03.17	Drug Makers Stocks Under Scanner -- Pfizer, Merck, AbbVie, and Johnson & Johnson (PR Newswire)
02.03.17	NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild-type mCRC (PR Newswire)
02.03.17	FDA Okays Odactra For House Dust Mite Allergies (RTTNews)
28.02.17	Merck, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts (RTTNews)
28.02.17	FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review (PR Newswire)
27.02.17	Biotech Stocks Facing FDA Decision In March (RTTNews)
26.02.17	Merck Reports Results Of Pivotal Phase 3 Clinical Study Of Letermovir (RTTNews)
24.02.17	Merck Gets Positive CHMP Opinion For New Pergoveris Fertility Pen (RTTNews)
24.02.17	Merck Receives Positive CHMP Opinion for New Pergoveris® Fertility Pen (PR Newswire)
21.02.17	Immunotherapy Companies Leading the Charge for Treating Cancer (PR Newswire)
15.02.17	AXSM On Fast Track, MRK Halts Alzheimer's Drug Study, HOLX Snaps Up CYNO (RTTNews)
15.02.17	Merck To Stop EPOCH Study; Doravirine Meets Primary Efficacy Endpoint (RTTNews)
09.02.17	Cladribine Tablets Significantly Reduced Brain Atrophy in Patients With Multiple Sclerosis (PR Newswire)
06.02.17	ESPR, MDCO Riding High, New Uses For MRK's Old Drug, DBVT In Full Smile(e) (RTTNews)
03.02.17	Newly released option reports for Boston Scientific Corporation, Cirrus Logic, Merck & Company Incorporated, Charles Schwab and Wells Fargo & Co. (PR Newswire)
03.02.17	Merck: FDA Accepts For Review Two SBLAs For Keytruda - Quick Facts (RTTNews)
02.02.17	Merck Q4 Adj. Profit Meets View, But Revenues Miss (RTTNews)
02.02.17	Merck & Co Inc. Earnings Drop 5% In Q4 (RTTNews)
31.01.17	Trump Calls For Increased Competition To Reduce Drug Prices (RTTNews)
20.01.17	Merck and Genea Open Centre of Excellence for Fertility (PR Newswire)
18.01.17	Technical Reports on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson (PR Newswire)
12.01.17	Investors: Covered-Call Reports for BB&T Corporation, Exelixis, Merck & Company Incorporated, Parsley Energy Inc and Workday (PR Newswire)
11.01.17	Lilly, Merck Expand Immuno-Oncology Collaboration (RTTNews)
11.01.17	So Long DSCI, MRK Seeks New Use For Old Drug, VRX Does It Again, PSTI On Watch (RTTNews)
09.01.17	Incyte & Merck Expand Clinical Trial On Combination Of Epacadostat With KEYTRUDA (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

11.12.24		Dow Jones-Handel aktuell: Dow Jones verbucht letztendlich Verluste
11.12.24		Schwache Performance in New York: Dow Jones gibt nachmittags nach
11.12.24		Gewinne in New York: Dow Jones verbucht am Mittwochmittag Zuschläge
11.12.24		Mittwochshandel in Zürich: SMI letztendlich mit Gewinnen
11.12.24		Börse London: FTSE 100 zum Ende des Mittwochshandels mit positivem Vorzeichen

11.12.24

Dow Jones-Handel aktuell: Dow Jones verbucht letztendlich Verluste

11.12.24

Schwache Performance in New York: Dow Jones gibt nachmittags nach

11.12.24

Gewinne in New York: Dow Jones verbucht am Mittwochmittag Zuschläge

11.12.24

Mittwochshandel in Zürich: SMI letztendlich mit Gewinnen

11.12.24

Börse London: FTSE 100 zum Ende des Mittwochshandels mit positivem Vorzeichen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu Merck Co.

Aktien Top/Flop

Merck Peer Group Nachrichten

Meistgelesene Nachrichten